Although a cure for MS has not yet been discovered, a number of medications (also called disease-modifying therapies, or DMTs) have been approved to treat MS. Research shows …

There is a large body of evidence that supports early and ongoing treatment with an approved disease-modifying therapy (DMT) as an evidence-based approach to reducing relapse activity, …

2024年10月19日 · This article presents the recommendations and suggestions for future research of an American Academy of Neurology (AAN) practice guideline on the efficacy and safety of …

2023年2月3日 · Many medications can slow down MS in some people. Doctors call them disease-modifying drugs. They include: How Do They Work? All of these drugs work by holding back or …

Disease modifying therapies (DMTs) aren't a cure for MS, but they can reduce how many relapses someone has and how serious they are. They can also slow down the damage …

The goal of MS disease-modifying therapy is to reduce the early clinical and subclinical disease activity that eventually contributes to long-term disability. 31,32 There are currently 13 FDA …

Multiple sclerosis (MS) is an immune-mediated inflammatory demyelinating disease of the central nervous system that is a leading cause of disability in young adults. The disease-modifying …

This update of the Multiple Sclerosis Therapy Consensus Group treatment recommendation focuses on the most important recommendations for disease-modifying therapies of multiple …

This is a summary of the American Academy of Neurology (AAN) publication, “Practice guideline recommendations: Disease-modifying therapies for adults with multiple sclerosis,” which was …

2024年9月25日 · The current goals for MS care are to reduce the frequency of relapses and to slow the progression of the disease by using a drug therapy approach called disease …